367 results on '"Femminella, Grazia Daniela"'
Search Results
2. Atrial Fibrillation and Dementia: Focus on Shared Pathophysiological Mechanisms and Therapeutic Implications
3. Role of frailty on cardiac rehabilitation in hospitalized older patients
4. The experiences of early career geriatricians throughout Europe during the COVID-19 pandemic
5. The elderly at risk: aldosterone as modulator of the immune response to SARS-CoV-2 infection
6. Impact of serum leptin and adiponectin levels on brain infarcts in patients with mild cognitive impairment and Alzheimer’s disease: a longitudinal analysis
7. Impact of the number of comorbidities on cardiac sympathetic derangement in patients with reduced ejection fraction heart failure
8. Cognitive profile in burning mouth syndrome versus mild cognitive impairment: A comparative study.
9. Dysfunctional cerebral glucose transport in Alzheimer’s Disease
10. MRI CHANGES FOLLOWING TREATMENT OF GLP‐1 ANALOGUE, LIRAGLUTIDE IN ALZHEIMER’S DISEASE
11. Personality and cognition in mild cognitive impairment: predictive role of neuroticism
12. Magnetic Resonance Spectroscopy metabolites as biomarkers of Alzheimer’s Disease
13. Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?
14. Intricate relationship between obstructive sleep apnea and dementia in older adults
15. Predisposing factors to heart failure in diabetic nephropathy: a look at the sympathetic nervous system hyperactivity
16. Impact of serum leptin and adiponectin levels on the development of brain infarcts in patients with mild cognitive impairment and Alzheimer’s disease
17. Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
18. Editorial: Chronic pain in neuropsychiatric diseases
19. Neuropsychiatric symptoms and their neural correlates in individuals with mild cognitive impairment
20. The Adrenergic System of the Myocardium
21. Interleukin-17 (IL-17) triggers systemic inflammation, peripheral vascular dysfunction, and related prothrombotic state in a mouse model of Alzheimer's disease
22. Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
23. Digital Health Service for Identification of Frailty Risk Factors in Community-Dwelling Older Adults: The SUNFRAIL+ Study Protocol
24. Cardiac sympathetic innervation and mortality risk scores in patients with heart failure
25. Interleukin-17 (IL-17) triggers systemic inflammation, peripheral vascular dysfunction, and related prothrombotic state in a mouse model of Alzheimer's disease
26. Cortical diffusivity associates with early neuronal damage
27. Impact of aging on cardiac sympathetic innervation measured by 123I-mIBG imaging in patients with systolic heart failure
28. Assessment Tools of Biopsychosocial Frailty Dimensions in Community-Dwelling Older Adults: A Narrative Review
29. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure
30. Long-Term Caloric Restriction Improves Cardiac Function, Remodeling, Adrenergic Responsiveness, and Sympathetic Innervation in a Model of Postischemic Heart Failure
31. Astrogliosis in aging and Parkinson’s disease dementia: a new clinical study with 11C-BU99008 PET
32. Muscle Ultrasound as Imaging Domain of Frailty
33. Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac 123I-MIBG study
34. The elderly at risk: aldosterone as modulator of the immune response to SARS-CoV-2 infection
35. Diabetes Mellitus and Parkinson’s Disease: A Systematic Review and Meta-Analyses
36. Editorial: Molecular Mechanisms Involved in Heart Failure, Parkinson’s, and Alzheimer’s Diseases
37. Cholinesterase inhibitors for Parkinsonʼs disease: a systematic review and meta-analysis
38. Molecular aspects of the cardioprotective effect of exercise in the elderly
39. Additional file 2 of Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?
40. Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
41. Correction to:Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: Study protocol for a randomised controlled trial (ELAD study) (Trials. (2019) 20 (191) DOI: 10.1186/s13063-019-3259-x)
42. Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker?
43. Influence of cerebral glucose metabolic rate on cognitive function in Alzheimer's subjects
44. Assessing the relationship between cognitive dysfunction and brain atrophy in Alzheimer's disease
45. Microglial activation evaluated using flutriciclamide ( 11 F‐GE180) in subjects with cognitive impairment
46. Relationship between spectral analysis, SUV and SUV Pons ratio as a measure of cerebral glucose metabolic rate in Alzheimer's disease
47. Functional indicators of a decline in the noradrenergic locus coeruleus in ageing
48. Behavioural symptoms in Alzheimer’s disease are associated with white matter lesions (WML) volume and are independent of atrophy and hypometabolism
49. Instruments for geriatric assessment: new multidimensional assessment approaches
50. Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement: the complexity of the elderly
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.